Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference

December 15, 2023

https://www.globenewswire.com/news-release/2023/11/02/2772309/0/en/Conduit-Pharmaceuticals-to-Participate-in-the-14th-Annual-Jefferies-London-Healthcare-Conference.html

SAN DIEGO and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) — Conduit Pharmaceuticals Inc. (Nasdaq:CDT) (“Conduit Pharmaceuticals” or “Conduit”), a multi-asset clinical-stage disease-agnostic life science company delivering an efficient model for compound development, today announced that its CEO, Dr. David Tapolczay, and its CFO, Adam Sragovicz, will be attending the 14th Annual Jefferies London Healthcare Conference, taking place from Tuesday, November 14 to Thursday, November 16.

Read more at globenewswire.com

Related news for (CDT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.